Calcitonin gene-related peptide (CGRP) is a 37 amino acid peptide, which is encoded by the same gene as calcitonin but is produced by alternative splicing of the RNA transcript of the calcitonin gene (Amara et al., 1982; Rosenfeld et al., 1983) .
By radioimmunoassay and immunocytochemistry, CGRP-like immunoreactivity (LI) was shown to exist both in the central and peripheral nervous system (Rosenfeld et al., 1983; Wiesenfeld-Hallin et al., 1984; Tschopp et al., 1984 and Kawai et al., 1985; Skofitsch and Jacobowitz 1985; Mulderry et al., 1985; Okimura et al., 1987; Tiller-Borcich et al., 1988) . In rat brain, high concentrations of CGRP-LI were reported in the medulla oblongata , and immunoreactive CGRP was found in several nuclei of the brain stem and in their fibers projecting to the hypothalamus (Rosenfeld et al., 1983) . In the rat hypothalamus, CGRP positive cell bodies were also observed in the paraventricular nucleus, arcuate nucleus, anterior nucleus, perifornical area and lateral area (Kawai et al., 1985; Skofitsch and Jacobowitz 1985) . CGRP may act as a neurotransmitter or neuromodulator.
CGRP-LI was also determined in the tion of the chloramine-T method (Hunter and Greenwood, 1962) without the addition of sodium metabisulfite. The radioimmunoassay showed 100% cross reaction with CGRP II (Steenbergh et al., 1985) Results By radioimmunoassay, CGRP-LI was detected in 2 human hypothalami (2.1 and 7.0ng/g wet tissue), the amounts being greater than those in the cerebral cortex (Table  1) . Serial twofold dilution curves of tissue extracts were parallel' with a standard curve of CGRP. Reverse phase HPLC revealed that most of the CGRP-LI in the human hypothalamus was eluted in an identical position with synthetic human CGRP, which was later than that of CGRP II, while a small amount of CGRP-LI was eluted in a more hydrophilic position than the elution positions of CGRP and CGRP II (Fig. 1) .
By immunocytochemistry, moderate numbers of CGRP immunoreactive cell bodies were found in the supraoptic CGRP immunoreactive cell bodies in the paraventricular nucleus (X40). V: third ventricle nucleus ( Fig.2-4 
Discussion
In this study, we detected CGRP-LI in the human hypothalamus in a radioimmunoassay.
By reverse phase HPLC, most of the CGRP-LI in the human hypothalamus was eluted in an identical position with synthetic human CGRP, although a small amount of CGRP-LI was found in a more hydrophilic position.
By immunocytochemistry, CGRP-LI was found in the cell bodies of the supraoptic nucleus, paraventricular nucleus and infundibular nucleus. These findings indicate that CGRP exists in the cell bodies of the human hypothalamic nuclei mentioned above.
The origin of CGRP-LI eluted in a more hydrophilic position in HPLC is not clear.
Further studies are needed to clarify whether this material is an artificial product of CGRP in the procedures of tissue extraction and HPLC, or a hydrophilic form of CGRP-like material.
High concentrations of CGRP in the pituitary glands were reported earlier TillerBorcich et al., 1988) .
From these reports and our finding that CGRP exists in the supraoptic nucleus, paraventricular nucleus and infundibular nucleus, it is suggested that CGRP plays a physiological role in the hypothalamo-pituitary system. In the human hypothalamus, arginine vasopressin and oxytocin were known to exist in the paraventricular nucleus and supraoptic nucleus and be transported through the nerve fibers to the pituitary gland (Dierickx and Vandesande 1977) . CGRP which exists in these nuclei may have some modulatory effects on the actions of arginine vasopressin and oxytocin. But further studies are needed to clarify if CGRP co-exists in the supraoptic nucleus and/or paraventricular nucleus with arginine vasopressin and/or oxytocin.
CGRP has a potent vasodilator action (Brain et al., 1985; Hanko et al., 1985) . The infusion of CGRP reduced gastric acid output, pepsin secretion and plasma levels of gastrin, gastric inhibitory peptide, enteroglucagon and neurotensin in man (Kraenzlin et al., 1985) . And intracisternal injection of CGRP inhibited gastric secretion in rats (Tache et al., 1984) . But the physiological roles of CGRP in the hypothalmo-pituitary system are not clear and need further investigation.
